Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cenix BioScience Joins EU FP7 Consortium for Discovery of miRNA Medicines

Published: Wednesday, August 14, 2013
Last Updated: Wednesday, August 14, 2013
Bookmark and Share
Company has joined an EU-funded consortium focused on the discovery of microRNA medicines in the area of cardiac and inflammatory metabolic diseases.

The consortium, named CardiomiR and funded by the EU FP7’s Marie Curie Actions program, was initially started in 2012 by the groups of Professor Stephane Heymans (Universiteit Maastricht, The Netherlands), Professor Louis Wehenkel (Université de Liège, Belgium) and Denmark-based Santaris Pharma A/S, with funds totaling over 1.6 million Euro. Cenix was recently invited to join the consortium for the remainder of the funding period, lasting until the end of 2015. The consortium’s updated project plan, now approved by the EU, will focus on identifying miRNAs that are implicated in adverse cardiac inflammation and metabolic risk factors resulting in heart failure, and to explore therapeutic interventions targeting these miRNAs. The Marie Curie funding will primarily support new recruitments and exchanges of scientific personnel by and between the consortium members, to productively combine their skills and know-how of miRNA inhibitor-based drug discovery and development, cardiac disease biology as well as systems biology and OMICS data analysis.

Cenix will complement the world-class expertise offered by the groups of Drs. Heymans and Wehenkel in these areas, by applying its capabilities in cell-based assay development and miRNA modulator screening, in vivo experimentation as well as bioinformatics. In particular, Cenix will leverage its state-of-the-art high-content screening platform using multi-parametric microscopy assays together with industry-leading Definiens XD image analysis, but also test in vivo delivery solutions, including its proprietary Cenix DARE™ technology.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Cenix, Metanomics Partner to Develop Metabolomic Biomarkers
Companies sign a research framework agreement focused on comprehensive metabolite profiling services and the development of metabolomic biomarkers.
Friday, September 05, 2014
Scientific News
Accessing Metabolic Information with Mass Spec
Scientists at the Helmholtz Zentrum München have developed a new mass spectrometry imaging method which, for the first time, makes it possible to analyze hundreds of metabolites in fixed tissue samples.
Improving Tumour Therapy with Nanoparticles
UHN nanoparticle called PEARLs is a promising utilisation of photo-thermal therapy for cancer treatment.
Exosome Research and Quality Control Using ZetaView
Particle Matrix's ZetaView particle characterisation system used by Cell Guidance Systems for exosome research.
Natural Metabolite Can Suppress Inflammation
An international group of scientists from US, Canada, Germany and Russia has revealed a substance produced in humans that can suppress the pro-inflammatory activity of macrophages – specific cells of immune system.
Some Women With PCOS May Have Adrenal Disorder
Researchers at NIH have found that a subgroup of women with PCOS, a leading cause of infertility, may produce excess adrenal hormones.
Making Metabolite Identification More Efficient
Metasense combines the industry's most-comprehensive metabolic transformation prediction with efficient analysis of LC/MS analytical measurements to identify, visualize, and report chemical biotransformations.
Mothers Obesity Could be Passed on in mtDNA
Obesity can predispose offspring in multiple generations to metabolic problems.
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Copper is Key in Burning Fat
Berkeley Lab scientist says results could provide new target for obesity research.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!